Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Jonathan Rosand

Neurocritical Care · Broad Institute

View

Dr. Jinsy Andrews

ALS · NYU Langone

View

Dr. Maisha Robinson

Hospice & Palliative Care · Mayo Clinic Florida

View

Dr. Michael Kentris

Epilepsy · St. Elizabeth Medical Center

View

Dr. Daniel Correa

Epilepsy · AECOM

View

Dr. Aaron Berkowitz

General Neurology · UCSF

View

Dr. Jose Hernan Posas

Sports Neurology · UVA

View

Dr. Michael Okun

Movement Disorders · UF

View

Dr. Joseph Sirven

Epilepsy · Mayo Clinic College of Medicine

View

Dr. Rachel Marie Salas

Sleep Medicine · Johns Hopkins

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Multiparametric MRI Model Predicts Parenchymal Hematoma in Acute Ischemic Stroke After Reperfusion.

    Jul 7, 2026DOI: 10.3174/ajnr.a9517Journal ArticleAJNR

    Written by: Mona AsghariahmadabadLucia ZimaAmeera IsmailMehmet KurtMersedeh Bahr-HosseiniJeffrey L SaverDavid S LiebeskindWade S SmithNerissa KoKazim NarsinhLuis E SavastanoVivek YedavalliJosep PuigEthan WinklerSteven W HettsS Andrew JosephsonChristopher P HessKambiz Nael

    Find these authors on Roon

    JS
    Dr. Jeffrey Saver
    Vascular Neurology · RRUCLA

    Summary

    BACKGROUND AND PURPOSE: Parenchymal hematoma (PH) is a severe complication of reperfusion therapy in acute ischemic stroke and is associated with poor functional outcome. We evaluated whether baseline quantitative imaging biomarkers derived from MR diffusion and perfusion could predict PH after reperfusion therapy.MATERIALS AND METHODS: In this retrospective study, consecutive adults with acute ischemic stroke due to large-vessel occlusion who underwent endovascular thrombectomy between 2015 and 2020 and had baseline MRI and follow-up imaging were included. Quantitative imaging biomarkers were extracted from the baseline ischemic core, including apparent diffusion coefficient (ADC), relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and relative K2 (rK2) derived from Bayesian-based DSC perfusion processing. The primary outcome was PH on follow-up imaging. Baseline imaging and clinical variables were compared between patients with and without PH. An elastic-net logistic regression model was developed using nested stratified group 5-fold cross-validation, and model performance was summarized by receiver operating characteristic analysis and SHAP-based feature importance.RESULTS: The final cohort included 100 patients, of whom 32 developed PH. Baseline demographic, clinical, and conventional imaging characteristics did not differ significantly between groups. Patients with PH had significantly lower values of rCBF, rCBV, and ADC and higher values of rK2 in comparison to those without PH. The final model incorporated 5th% ADC, rCBF, rCBV, and 95th% rK2 showed discrimination with an AUC of 0.88 ± 0.07 (mean ± SD) and overall accuracy of 77%.CONCLUSIONS: We developed a quantitative model using ADC, rCBV, rCBF, and rK2 from bassline MRI that can identify stroke patients with an increased risk of PH with approximately 77% accuracy.
    JS

    Dr. Jeffrey Saver

    Neurology · Vascular Neurology
    Ronald Reagan UCLA Medical Center
    jeffreysaver